Welcome to the meeting on the Innovative Medicines Initiative (IMI)

Are you interested in life sciences and drug development? Vinnova has invited the director of the IMI office in Brussels, Pierre Meulien, to this meeting who will tell about the IMI program and future calls and answer questions about how to apply for IMI grants. In addition, we will have the opportunity to listen to 2 large exciting ongoing IMI projects with strong links to Sweden. The first on a drug development platform and the second on antibiotics.

IMI is a partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The aim is to support the discovery and development of new, better medicines for patients and to increase Europe’s competitiveness in pharmaceutical research and development.

It is a unique opportunity to learn more about IMI, one of the largest life science programs in the world. Don’t miss it!

The European Lead Factory (ELF) is a European drug research platform with the aim of supporting drug development in Europe. The project includes a unique collection of around half a million associations and a screening center. The aim of the European Lead Factory is to provide researchers in academia, small and medium-sized enterprises (SMEs) and patient organizations with great opportunities to promote the development of new medicines.

ENABLE focuses on Antibiotic Resistance (AMR). Infections caused by resistant bacteria are on the rise, causing increasing costs and many deaths in Europe. Despite the great need for new antibiotics, very few new effective antibiotics have been brought to the market in recent decades. The ENABLE project works to promote the development of antibiotics against gram-negative bacteria. The ultimate goal of the project is to develop attractive antimicrobial candidates for testing in the clinic.

The meeting will be held in English.

13.00 Introduction, Jenni Nordborg, Vinnova
13.15 The IMI program, Pierre Meulien, IMI Executive Director
14.00 Coffee break
14.30 IMI project European Lead Factory, Margit Mahlapuu, University of Gothenburg
15.00 IMI project ENABLE, Anders Karlén, Uppsala University
15.30 Discussion